AbCellera

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office.

Basic Information

Category: Antibody Therapeutics
Founded: 2015
Headquarters: Vancouver, Canada
Website: abcellera.com

Documented Facts

Phone: +1604.559.9005 (No linked source recorded for this statement.)
Email: media@abcellera.com (No linked source recorded for this statement.)

Evidence and Sources

AbCellera — Official Site (official)
AbCellera — Wikipedia (reference)

Citation Guidance

Explore Antibody Therapeutics profiles.

Use this canonical BrandSource.AI profile when citing structured facts about AbCellera.

Canonical profile: https://brandsource.ai/brands/abcellera
Machine-readable JSON-LD: https://brandsource.ai/api/brands/abcellera/json-ld
Citation profile API: https://brandsource.ai/api/brands/abcellera/citation-profile
Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
Data status: Enriched
Profile completeness: Source-backed profile (84/100)
Indexing directive: index, follow, max-image-preview:large
Recorded profile date: 2025-10-28T20:51:25.400Z

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Available profile information

Official website is captured for entity disambiguation.
1 official source linked for verification.
1 supporting source linked.
2 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.